Advertenties
14.6
Referenties
1.
Coons AH et al. Immunological properties of an antibody containing a fluorescent group. Proc
Soc Exp Biol Med 1941; 47:200-202.
2.
Nakane PK and Pierce GB Jr. Enzyme labeled antibodies: Preparations and applications for the
localizations of antigens. J Histochem Cytochem 1967; 14:929-931.
3.
Elias JM, Gown AM, Nakamura RM, Wilbur DC, Herman GE, Jaffe ES, Battifora H, and Brigati J.
Special report: Quality control in immunohistochemistry. Am J Clin Path 1989; 92:836.
4.
Nadji M and Morales AR. Immunoperoxidase techniques: a practical approach to tumor
diagnosis. ASCP Press, Chicago. 1986.
5.
True LD ed. Atlas of Diagnostic Immunohistopathology. Lippincott, Philadelphia.1990.
6.
Gall JG, Pardue ML. Formation of RNA-DNA hybrid molecules in cytological preparation.
Proceedings of the National Academy of the Sciences of the United States of America.
1969;63:378-383.
7.
Shi S-R, Gu J, and Taylor CR. Antigen Retrieval Techniques: Immunohistochemistry and
Molecular Morphology. Eaton Publishing, Natick. 2000.
8.
Miller RT, Swanson PE, and Wick MR. Fixation and epitope retrieval in diagnostic
immunohistochemistry: a concise review with practical considerations. Appl Immunohistochem
Mol Morphol. 2000 Sep;8(3):228-35.
9.
Bancroft JD and Stevens A. Theory and Practice of Histological Techniques. 4th Edition.
Churchill Livingstone, New York. 1996.
10. Wolff et al. American Society of Clinical Oncology/College of American Pathologists Guideline
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer.
Arch Pathol Lab Med 2007; 131:18–43.
11. Kiernan JA. Histological and Histochemical Methods: Theory and Practice. New York: Pergamon
Press. 1981.
12. Sheehan DC. and Hrapchak BB. Theory and Practice of Histotechnology. St. Louis: C.V. Mosby
Co. 1980.
13. Clinical Laboratory Improvement Amendments of 1988, Final Rule 57 FR 7163 February 28,
1992.
14. O'Leary TJ, Edmonds P, Floyd AD, Mesa-Tejada R, Robinowitz M, Takes PA, Taylor CR. Quality
assurance for immunocytochemistry; Proposed guideline. MM4-P. National Committee for
Clinical Laboratory Standards (NCCLS). Wayne, PA. 1997;1-46.
15. Battifora H. Diagnostic uses of antibodies to keratins: a review and immunohistochemical
comparison of seven monoclonal and three polyclonal antibodies. Progress in Surg Path 6:1-15.
eds. Fenoglio-Preiser C, Wolff CM, Rilke F. Field & Wood, Inc., Philadelphia.
16. College of American Pathologists (CAP) Certification Program for Immunohistochemistry.
Northfield IL. http://www.cap.org
17. Wilkinson DG. The theory and practice of in situ hybridisation. In: Wilkinson DG. (ed.) In Situ
Hybridization A practical approach. 2nd Edition. New York: Oxford University Press, 1998,
pp.18-20.
18. Nadji M, Morales AR. Immunoperoxidase, part I: the techniques and pitfalls. Lab Med 1983;
14:767.
19. Omata M, Liew CT, Ashcavai M, and Peters RL. Nonimmunologic binding of horseradish
peroxidase to hepatitis B surface antigen: a possible source of error in immunohistochemistry.
Am J Clin Path 1980;73:626.
20. Wilkinson DG. In situ hybridization: A practical approach. 2nd Edition. Oxford University Press,
Oxford. 1998.
21. Weiss LM, Chen Y. Effects of different fixatives on detection of nucleic acids from paraffin-
embedded tissues by in situ hybridization using oligonucleotide probes. The Journal of
Histochemistry and Cytochemistry. 1991;39(9):1237-1242.
BOND 6.0 gebruikshandleiding (NIET VS en China) rev. A05 © Leica Biosystems Melbourne Pty Ltd 2021
BOND reagentia gebruiken
304
Advertenties
